Reglan, a prescription drug indicated for digestive aid, has been linked to tardive dyskinesia, a dangerous neurological disorder. Tardive dyskinesia is characterized by involuntary, continual movements of the face and extremities. These movements can include, but are not limited to changing facial expressions, tongue protrusion, lip smacking, lip puckering, lip pursing, rapid blinking, and rapid finger movement. Tardive dyskinesia has no known cure, and may persist permanently after discontinuing the use of Reglan.
Lawsuits against the makers of Reglan, Qualities Pharmaceuticals, have accused the company of not including warnings about the dangers of contracting tardive dyskinesia while taking Reglan. Perona, Langer, Beck, Serbin and Mendoza is actively pursuing litigation on behalf of victims who contracted tardive dyskinesia while prescribed Reglan.